This gives us an opportunity to give our two cents and showcase something a bit different for today's Formulator's Corner profile
Adjust your medication regimen and/or carbohydrate intake as needed to prevent hypoglycemia or hyperglycemia during exercise
Glucagon-like peptide-1 (GLP-1) agonists are a class of medications frequently used to treat type 2 diabetes mellitus (T2DM) and obesity.[1] This class of medications assists in lowering blood sugar levels and promotes weight loss
[28] The most frequently observed are nausea, diarrhea, and vomiting, which increased in incidence with the dosage amount (that is, the higher the dose, the higher the likelihood of side effects)
In contrast, TIGAR overexpression or treatment with Fer-1, a ferroptosis inhibitor, significantly increases NADPH, GPX4, and GSH levels, reduces GSSG expression, and attenuates neuronal ferroptosis and neurological impairment
However, with both Ozempic and Tirzepatide on the market, many wonder if one is better